Aarti Pharmalabs
AARTIPHARM · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 30, 2023

Stock Price vs Company Growth
1d
-0.0%
1w
2.0%
1m
13.2%
3m
0.6%
6m
31.5%
1y
30.8%
all
27.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 511 -0.0%
381
564
Company Overview

Sales
1,832 Cr
Growth: -4.6%
Profit after Tax
195 Cr
Growth: 2.7%
Small Cap
4,634 Cr
P/E: 23.8x
Industry P/E: 35.0x
Fundamentals

Sales (Cr) ₹ 1,832
Growth -4.6%
EBITDA 19.0%
P/S 2.5x
Dividend 0.4%
P/E 23.8x
Book Value ₹ 189
PEG Ratio -5.1x
ROE 11.9%
P/B 2.7x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is an, internationally recognised manufacturer of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, New Chemical Entities (NCE), and xanthine derivatives situated in India. In order to build a sustainable future, it integrates process chemistry proficiency (recipe focus) with scale-up engineering proficiency (asset utilisation).
Investors (8)